GABRIEL LOPEZ to Breast Neoplasms
This is a "connection" page, showing publications GABRIEL LOPEZ has written about Breast Neoplasms.
Connection Strength
0.489
-
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis. 2012 Oct; 33(10):1843-53.
Score: 0.074
-
Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene. 2002 Aug 08; 21(34):5224-32.
Score: 0.037
-
Bcl-2-related antisense therapy. Semin Oncol. 2002 Jun; 29(3 Suppl 11):71-6.
Score: 0.037
-
Modulation of Akt activity by doxorubicin in breast cancer cells. J Chemother. 2001 Jun; 13(3):334-6.
Score: 0.035
-
Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells. Oncogene. 2000 Dec 14; 19(54):6271-6.
Score: 0.033
-
Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene. 1999 Feb 11; 18(6):1325-32.
Score: 0.029
-
A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer. Hum Gene Ther. 1998 Aug 10; 9(12):1775-98.
Score: 0.028
-
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers. Cancer Cell. 2014 Dec 08; 26(6):863-879.
Score: 0.022
-
Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer. PLoS One. 2012; 7(7):e41171.
Score: 0.019
-
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer. Breast Cancer Res. 2012 Jul 19; 14(4):R108.
Score: 0.019
-
Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer. Hum Pathol. 2012 Oct; 43(10):1638-44.
Score: 0.018
-
Chitosan hydrogel for localized gene silencing. Cancer Biol Ther. 2011 May 01; 11(9):839-45.
Score: 0.017
-
Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model. Mol Cancer Ther. 2010 May; 9(5):1180-7.
Score: 0.016
-
Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy. 2008 Jul; 4(5):669-79.
Score: 0.014
-
Silk fibroin mediated delivery of liposomal emodin to breast cancer cells. Int J Pharm. 2007 Aug 16; 341(1-2):221-9.
Score: 0.013
-
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model. Cancer Gene Ther. 2006 Jul; 13(7):706-19.
Score: 0.012
-
Liposomal antisense oligonucleotides for cancer therapy. Methods Enzymol. 2004; 387:241-53.
Score: 0.010
-
Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun. 2002 Jul 26; 295(4):784-90.
Score: 0.009
-
The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002. Clin Cancer Res. 2002 Apr; 8(4):955-6.
Score: 0.009
-
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol. 2001 Jul 15; 19(14):3422-33.
Score: 0.009
-
Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer. Clin Cancer Res. 2001 May; 7(5):1237-45.
Score: 0.009
-
Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively. Int J Cancer. 2000 Apr 15; 86(2):295-7.
Score: 0.008
-
Tumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013; 4:2427.
Score: 0.005
-
Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008 Dec 18; 359(25):2641-50.
Score: 0.004
-
The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues. J Immunol. 1983 Apr; 130(4):1500-2.
Score: 0.002